mGy·MBq−1 | Kidneys | Liver | Liver excluding tumor | Lungs | Spleen | RM* | Whole body | Effective dose (mSv·MBq−1) |
M-1 | 0.82 | 1.54 | 1.61 | 0.50 | 0.79 | 0.46 | 0.45 | 0.52 |
M-2 | 0.93 | 2.00 | 2.07 | 0.55 | 0.74 | 0.52 | 0.45 | 0.55 |
M-3 | 0.82 | 2.18 | 2.68 | 0.52 | 0.71 | 0.50 | 0.45 | 0.54 |
M-4 | 0.83 | 2.42 | 2.42 | 0.51 | 0.62 | 0.49 | 0.45 | 0.55 |
F-1 | 1.24 | 2.91 | 2.91 | 0.86 | 1.11 | 0.56 | 0.56 | 0.70 |
F-2 | 1.32 | 3.48 | 3.67 | 0.80 | 1.10 | 0.44 | 0.56 | 0.71 |
F-3 | 1.30 | 3.64 | 3.69 | 0.85 | 1.15 | 0.63 | 0.56 | 0.72 |
5-time-point dosimetry approach | ||||||||
Mean | 1.04 | 2.60 | 2.72 | 0.66 | 0.89 | 0.51 | 0.50 | 0.61 |
SD | 0.24 | 0.78 | 0.78 | 0.17 | 0.22 | 0.06 | 0.06 | 0.09 |
Simplified 3-time-point dosimetry approach | ||||||||
Mean | 1.04 | 2.50 | — | 0.66 | 0.91 | 0.50 | 0.50 | 0.61 |
SD | 0.22 | 0.75 | — | 0.17 | 0.22 | 0.06 | 0.06 | 0.09 |
↵* Based on manual VOI delineation method.